NL302572A - - Google Patents

Info

Publication number
NL302572A
NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302572A publication Critical patent/NL302572A/xx

Links

NL302572D 1962-12-27 NL302572A (cs)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP6427663 1963-10-29
JP5741963 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
NL302572A true NL302572A (cs)

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302572D NL302572A (cs) 1962-12-27

Country Status (5)

Country Link
BE (1) BE641880A (cs)
FR (1) FR3150M (cs)
GB (1) GB1080599A (cs)
LU (1) LU45106A1 (cs)
NL (1) NL302572A (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
PL2319581T3 (pl) 2004-11-26 2015-10-30 Ucl Business Plc Kompozycje zawierające ornitynę i fenylooctan lub fenylomaślan do leczenia encefalopatii wątrobowej
MX388894B (es) 2009-04-03 2025-03-20 Ocera Therapeutics Inc Fenil acetato de l-ornitina y metodos para elaborar el mismo
MX375116B (es) 2009-06-08 2025-03-06 Ucl Business Plc Tratamiento de hipertension portal y restauracion de la funcion hepatica usando fenilacetato de l-ornitina.
WO2012048043A1 (en) 2010-10-06 2012-04-12 Ocera Therapeutics, Inc. Methods of making l-ornithine phenyl acetate
JP6797117B2 (ja) 2014-11-24 2020-12-09 ユーシーエル ビジネス リミテッド アンモニア降下療法を用いた肝星細胞活性化関連疾患の処置
CA2995823A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
WO2018208677A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
BE641880A (cs) 1964-04-16
FR3150M (fr) 1965-02-22
LU45106A1 (cs) 1964-02-24
GB1080599A (en) 1967-08-23

Similar Documents

Publication Publication Date Title
BE630640A (cs)
BE616548R (cs)
BE616785A (cs)
BE629944A (cs)
NL302572A (cs)
BE633369A (cs)
BE632172A (cs)
BE631769A (cs)
BE631669A (cs)
BE631269A (cs)
BE613190A (cs)
BE616386A (cs)
BE616490A (cs)
BE629880A (cs)
BE629872A (cs)
BE629378A (cs)
BE628946A (cs)
BE628701A (cs)
BE627733A (cs)
BE627394A (cs)
BE627343A (cs)
BE622858A (cs)
BE620262A (cs)
BE630333A (cs)
BE630619A (cs)